Last $3.74 USD
Change Today +0.05 / 1.36%
Volume 41.0K
BVX On Other Exchanges
As of 4:15 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/2/14 - $5.00
52 Week Low
02/3/14 - $2.67
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation, an energy-based medical device company, develops, manufactures, and markets a range of electrosurgical products and technologies, and related medical products worldwide. The company’s electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers battery operated cauteries; and battery operated medical lights for use in ophthalmology, as well as for general surgery, hip replacement surgery, and the placement of endotracheal tubes in emergency and surgical procedures. In addition, the company manufactures physicians’ office use penlights; and a nerve locator stimulator used for identifying motor nerves in hand and facial reconstructive surgery. Further, Bovie Medical Corporation is developing Derm 101 and Derm 102 products, which are 10 watt high frequency desiccators for use in family practice, aesthetics, and dermatology settings; and Seal-N-Cut, a disposable endoscopic surgical handle. The company markets its products through medical distributors to hospitals, doctor’s offices, and other healthcare facilities. Bovie Medical Corporation was founded in 1982 and is based in Clearwater, Florida.

136 Employees
Last Reported Date: 05/8/14
Founded in 1982

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $56.7K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $305.2K
Executive Chairman
Total Annual Compensation: $215.5K
Senior Vice President
Total Annual Compensation: $204.8K
Compensation as of Fiscal Year 2013.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Provides Update on Recent Developments for J-Plasma

Bovie Medical Corporation provided an update on recent developments for J-Plasma. The company announced that all J-Plasma disposable hand pieces as well as the Bovie Ultimate generator have received CE Mark approval for compliance with European Union safety, health and environmental protection requirements. As a result, the company will be able to sell these devices in the 31 countries of the European Economic Area.

Bovie Seeks Acquisitions

Bovie Medical Corporation (AMEX:BVX) is looking for acquisition opportunities. Bovie has filed a shelf registration of $25 million. Bovie stated, “We currently intend to use the net proceeds from the sale of securities offered by this prospectus for the continued development and marketing of our J-Plasma® technology and for working capital and other general corporate purposes, including capital expenditures, facilities expansion, acquisitions of complementary products, technologies or businesses and repaying indebtedness we may incur from time to time.”

Bovie Medical Receives FDA 510(k) Approval for Bovie Ultimate Generator

The Bovie Ultimate is a high frequency electrosurgical generator that can be used for delivery of RF energy and/or helium gas plasma to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The generator offers users monopolar, bipolar and plasma features, including one J-Plasma helium gas outlet, in a single generator. Its pad-sensing system reduces the risk of patient burns, but this feature is not required when using helium gas mode for soft tissue coagulation. The Bovie Ultimateâ„¢ will replace Bovie's ICON GS plasma system. The Company expects commercial launch of the new product in February, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $3.74 USD +0.05

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $47.61 USD +0.47
STAAR Surgical Co $5.86 USD +0.15
Stereotaxis Inc $1.62 USD -0.02
Vascular Solutions Inc $29.08 USD +0.73
View Industry Companies

Industry Analysis


Industry Average

Valuation BVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 9.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at